For decades, cannabis has been portrayed as an illegal drug with no medical value. As more research supporting the therapeutic potential of cannabis has emerged, many medical professionals accept that cannabis may offer relief as an alternative treatment option for a number of ailments and conditions.
In recent years, there have been a variety of cannabis medicines developed with various cannabinoid profiles and formulations. Some studies have shown that specific combinations of cannabinoids and terpenes may mimic the therapeutic effects of conventional medications, making it possible for patients to manage symptoms, take control of their medical regimens, and reduce dependency.
For many patients, medical cannabis is becoming an accepted mainstream alternative to traditional pharmaceuticals that often have negative side effects and an impact on quality of life. Aruma is working to contribute to the advancement of treatment options for Australian patients through specialised, targeted formulations and new methods of treating a variety of symptoms and conditions.
A survey conducted on medical cannabis patients showed that many patients seeking to lower prescription medication doses were successfully able to do so by implementing cannabis into their medical regimen. The study, published in the Journal of Pain Research, presented the results of a survey conducted on a sample of 2,774 cannabis consumers- 46% reported using cannabis in place of prescription medications. 36% replaced pain-relieving narcotics and opioids with cannabis, 14% replaced anti-anxiety medications with cannabis, and 13% replaced antidepressants with cannabis.
Modifying a prescription medication dosage is not a casual undertaking and should not be done without the advice, consent and direction of the prescribing physician. Patients should never modify their prescription regiment without first fully discussing it with their physician. Although, education regarding therapeutic cannabis has typically not been included as part of traditional medical curriculum, many physicians have self-educated themselves in order to provide insight to patients inquiring about cannabis-derived medicines.